These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 5675488)

  • 1. Tardive dyskinesia in schizophrenic patients treated with psychotropic drugs.
    Crane GE
    Agressologie; 1968; 9(2):209-18. PubMed ID: 5675488
    [No Abstract]   [Full Text] [Related]  

  • 2. Epidemiology of tardive dyskinesia. Part II.
    Jus A; Pineau R; Lachance R; Pelchat G; Jus K; Pires P; Villeneuve R
    Dis Nerv Syst; 1976 May; 37(5):257-61. PubMed ID: 1261344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium carbonate in the treatment of tardive dyskinesia.
    Reda FA; Escobar JI; Scanlan JM
    Am J Psychiatry; 1975 May; 132(5):560-2. PubMed ID: 804260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical observations of the treatment of tardive dyskinesia with haloperidol.
    Frangos E; Christodoulides H
    Acta Psychiatr Belg; 1975 Jan; 75(1):19-32. PubMed ID: 785948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polygraphic studies of tardive dyskinesia and of the rabbit symdrome during different stages of sleep.
    Villeneuve A; Jus K; Jus A
    Biol Psychiatry; 1973 Jun; 6(3):259-74. PubMed ID: 4732255
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of drug withdrawal on tardive dyskinesia.
    Crane GE; Ruiz P; Kernohan WJ; Wilson W; Royalty N
    Act Nerv Super (Praha); 1969; 11(1):30-5. PubMed ID: 5770140
    [No Abstract]   [Full Text] [Related]  

  • 7. [Side effects of psychopharmacologic agents simulating neurologic disease symptoms].
    Möllhoff G
    Lebensversicher Med; 1969 Jul; 21(4):85-9. PubMed ID: 4389764
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of withdrawal of antiparkinsonian medication on chronically hospitalized psychiatric patients.
    Ananth JV; Horodesky S; Lehmann HE; Ban TA
    Laval Med; 1970 Sep; 41(7):934-8. PubMed ID: 5509491
    [No Abstract]   [Full Text] [Related]  

  • 9. A controlled comparison of oxypertine and perphenazine in schizophrenic psychoses.
    Svestka J; Náhunek K; Rodová A; Cesková E
    Act Nerv Super (Praha); 1974 Aug; 16(3):165-6. PubMed ID: 4608706
    [No Abstract]   [Full Text] [Related]  

  • 10. [Movement disorders as a concomitant syndrome in the use of psychopharmacological agents].
    von der Mühlen H
    Z Allgemeinmed; 1973 Oct; 49(30):1441-7. PubMed ID: 4768492
    [No Abstract]   [Full Text] [Related]  

  • 11. [The semiology of motor function disorders during treatment with neuroleptic drugs].
    Fleĭs EP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(12):1798-804. PubMed ID: 5511943
    [No Abstract]   [Full Text] [Related]  

  • 12. Tardive dyskinesia: its relation to neuroleptic and antiparkinson drugs.
    Turek I; Kurland AA; Hanlon TE; Bohm M
    Br J Psychiatry; 1972 Dec; 121(565):605-12. PubMed ID: 4648433
    [No Abstract]   [Full Text] [Related]  

  • 13. [Late dyskinesia caused by neuroleptics. Survey on 1,660 psychiatric hospital patients].
    Bourgeois M; Graux C; Arrethche-Berthelot N
    Ann Med Psychol (Paris); 1976 May; 1(5):737-46. PubMed ID: 970829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Extrapyramidal syndrome and spondyloarthritis ankylopoietica in a schizophrenic patient].
    Lipiński B
    Psychiatr Pol; 1970; 4(2):211-4. PubMed ID: 5427765
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical trials with thiothixene.
    Köknel O
    Dis Nerv Syst; 1968 Nov; 29(11):754-9. PubMed ID: 4887394
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the problem of the terminal extrapyramidal hyperkineses as observed in 1600 patients during long-term therapy with neuroleptics].
    Degkwitz R; Wenzel W; Binsack KF; Herkert H; Luxenburger O
    Arzneimittelforschung; 1966 Feb; 16(2):276-9. PubMed ID: 4861657
    [No Abstract]   [Full Text] [Related]  

  • 17. Pseudoparkinsonism and tardive dyskinesia.
    Crane GE
    Arch Neurol; 1972 Nov; 27(5):426-30. PubMed ID: 5078897
    [No Abstract]   [Full Text] [Related]  

  • 18. [Paroxysmal extrapyramidal syndrome caused by taking neuroleptic drugs].
    Gurovich IIa; Fleĭs EP
    Klin Med (Mosk); 1969 Sep; 47(9):132-7. PubMed ID: 5397873
    [No Abstract]   [Full Text] [Related]  

  • 19. [Thromboembolism complications in neuro- and thymoleptic therapy].
    Meier-Ewert K; Baumgart HH; Friedenberg P
    Dtsch Med Wochenschr; 1967 Nov; 92(47):2174-8. PubMed ID: 6060874
    [No Abstract]   [Full Text] [Related]  

  • 20. [Secondary neurologic manifestations of psychotropic therapeutics. Neurophysiological approach].
    Rigal J; Savelli A; Juillet P
    Ann Med Interne (Paris); 1972 May; 123(5):541-7. PubMed ID: 4263578
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.